Beclazone Easi-Breathe to be phased out

Teva has confirmed that they will cease supply of all strengths of Beclazone Easi-Breathe (beclometasone diproprionate) inhalers from 30 September 2009. The inhalers are being discontinued in line with the Montreal Protocol requirements to phase out manufacture of all CFC-containing beclometasone products by 2010.

Patients on Beclazone Easi-Breathe will need to be transferred to an alternative device and/or product that suits the patient.

The discontinuation does not affect Qvar Easi-Breathe or Salamol Easi-Breathe.

View Beclazone Easi-Breathe drug record

Further information: Teva

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

New products - live tracker

New products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products added...

Drug price changes - live tracker

Drug price changes - live tracker

EXCLUSIVE TO SUBSCRIBERS Use our constantly updated...

Direct-acting oral anticoagulants set for wider use under NHS deal

Direct-acting oral anticoagulants set for wider use under NHS deal

More than half a million more people will be able to...

NICE recommends SGLT2 inhibitors for chronic kidney disease

NICE recommends SGLT2 inhibitors for chronic kidney disease

Updated NICE guidance on type II diabetes recommends...